These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23369686)

  • 1. Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4.
    Ty N; Pontikis R; Chabot GG; Devillers E; Quentin L; Bourg S; Florent JC
    Bioorg Med Chem; 2013 Mar; 21(5):1357-66. PubMed ID: 23369686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation.
    Li YW; Liu J; Liu N; Shi D; Zhou XT; Lv JG; Zhu J; Zheng CH; Zhou YJ
    Bioorg Med Chem; 2011 Jun; 19(11):3579-84. PubMed ID: 21536450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of cis-locked vinylogous combretastatin-A4 analogues: derivatives with a cyclopropyl-vinyl or a cyclopropyl-amide bridge.
    Ty N; Kaffy J; Arrault A; Thoret S; Pontikis R; Dubois J; Morin-Allory L; Florent JC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1318-22. PubMed ID: 19211248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concise synthesis of pyrazole analogues of combretastatin A1 as potent anti-tubulin agents.
    Zaninetti R; Cortese SV; Aprile S; Massarotti A; Canonico PL; Sorba G; Grosa G; Genazzani AA; Pirali T
    ChemMedChem; 2013 Apr; 8(4):633-43. PubMed ID: 23436706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4.
    Mur Blanch N; Chabot GG; Quentin L; Scherman D; Bourg S; Dauzonne D
    Eur J Med Chem; 2012 Aug; 54():22-32. PubMed ID: 22647220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.
    Fürst R; Zupkó I; Berényi A; Ecker GF; Rinner U
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6948-51. PubMed ID: 19879758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
    Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
    Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
    J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of indole compounds derived from combretastatin A4: synthesis and biological screening of 5-phenylpyrrolo[3,4-a]carbazole-1,3-diones as potential antivascular agents.
    Ty N; Dupeyre G; Chabot GG; Seguin J; Quentin L; Chiaroni A; Tillequin F; Scherman D; Michel S; Cachet X
    Eur J Med Chem; 2010 Sep; 45(9):3726-39. PubMed ID: 20538383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues.
    Guan Q; Zuo D; Jiang N; Qi H; Zhai Y; Bai Z; Feng D; Yang L; Jiang M; Bao K; Li C; Wu Y; Zhang W
    Bioorg Med Chem Lett; 2015 Feb; 25(3):631-4. PubMed ID: 25529737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
    Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
    Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
    Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
    Aziz J; Brachet E; Hamze A; Peyrat JF; Bernadat G; Morvan E; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Tueni M; Yassine A; Brion JD; Alami M
    Org Biomol Chem; 2013 Jan; 11(3):430-42. PubMed ID: 23047722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
    Ruan BF; Lu X; Tang JF; Wei Y; Wang XL; Zhang YB; Wang LS; Zhu HL
    Bioorg Med Chem; 2011 Apr; 19(8):2688-95. PubMed ID: 21440448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4.
    Sun J; Chen L; Liu C; Wang Z; Zuo D; Pan J; Qi H; Bao K; Wu Y; Zhang W
    Chem Biol Drug Des; 2015 Dec; 86(6):1541-7. PubMed ID: 26202587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.
    Akselsen OW; Odlo K; Cheng JJ; Maccari G; Botta M; Hansen TV
    Bioorg Med Chem; 2012 Jan; 20(1):234-42. PubMed ID: 22137934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.